← Back to headlines
Novo Nordisk to Invest €430 Million in Irish Plant for Weight Loss Drug Production
Pharmaceutical company Novo Nordisk announced a €430 million expansion of its manufacturing operation in Athlone, Ireland, to produce the tablet form of its weight loss drug Wegovy.
2 Mar, 09:31 — 2 Mar, 09:31
ℹOnly 1 source covers this story
Related Stories
NBI raids in Binondo yield over P237-M fake goods
just now
Fry scarcity hits ‘bangus’ growers in Pangasinan
just now
The internet is roasting these 4 young Wall Streeters for a glossy magazine spread. One of them is brushing it off.
12m ago
Block employee says the company dangled a 75% pay raise to get her to stay after layoffs — but she decided to quit
16m ago